#1292ef

HUTCHMED

#f9f9f9

Elina Ji

Joyce Jiang

Norman Ng

Selina Zhang

Hank Lam

Karen Atkin

Rachel Jin

Mandy Lee

Nicole Mak

Audrie Huang

About Us
is  an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.
We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.
is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange?s AIM market (Nasdaq/AIM: HCM ; HKEX: 13 ).
2000
FOUNDED
HCM
NASDAQ &
LONDON AIM
13
HKEX
13
IN-HOUSE DISCOVERED
CLINICAL STAGE CANCER
DRUG CANDIDATES
What We Do
Fully integrated platform built over 20 years.
Leadership
Our Board of Directors and Management Team.
Recent News
Our most up-to-date news and press releases

HUTCHMED (Nasdaq/AIM:HCM;HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.?
?????????/??????HCM?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????